|
Delayed
Bombay S.E.
05:24:16 08/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 12.40 INR | +1.97% |
|
+2.48% | -36.41% |
| 08-15 | Nectar Lifesciences Limited Changes Its Corporate Office in Chandigarh | CI |
| 08-14 | Nectar Lifesciences Limited Announces Board and Committee Changes, Effective August 14, 2026 | CI |
| Market Cap | 2.34B 24.79M 21.32M 20.05M 18.31M 34.24M 34.35M 238M 91.91M 1.2B 93.11M 91.07M 3.82B | P/E 2025 |
-4.53x | P/E 2026 | -0.69x |
|---|---|---|---|---|---|
| Enterprise Value | 1.09B 11.56M 9.95M 9.35M 8.54M 15.97M 16.02M 111M 42.87M 560M 43.43M 42.48M 1.78B | EV / Sales 2025 |
0.64x | EV / Sales 2026 | - |
| Free-Float |
44.34% | Yield 2025 * |
-
| Yield 2026 | - |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| NECLIFE | Delayed | |
Bombay S.E.
| NECLIFE | Delayed |
| 1 day | +1.97% | ||
| 1 week | +2.48% | ||
| Current month | -0.72% | ||
| 1 month | +17.31% | ||
| 3 months | +7.27% | ||
| 6 months | +9.54% | ||
| Current year | -36.41% |
| 1 week | 11.71 | 12.72 | |
| 1 month | 10.16 | 13.4 | |
| Current year | 9.2 | 20.94 | |
| 1 year | 9.2 | 22.49 | |
| 3 years | 9.2 | 56.39 | |
| 5 years | 9.2 | 56.39 | |
| 10 years | 7.2 | 56.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sushil Kapoor
DFI | Director of Finance/CFO | 68 | 13/11/2022 |
| Compliance Officer | - | 31/03/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Sanjiv Goyal
CHM | Chairman | 66 | 26/06/1995 |
Rupinder Tewari
BRD | Director/Board Member | 69 | 10/02/2019 |
| Director/Board Member | 75 | 20/09/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.97% | +2.48% | - | - | 25.08M | ||
| -0.44% | -2.26% | +19.26% | +66.79% | 48.26B | ||
| +0.60% | -4.76% | +39.20% | +117.99% | 40.5B | ||
| -0.40% | -2.37% | -9.86% | +11.63% | 11.85B | ||
| -0.60% | -1.46% | +13.97% | +83.19% | 11.83B | ||
| -1.50% | -0.38% | +24.76% | +138.18% | 9.36B | ||
| -0.86% | -3.20% | +23.76% | +38.38% | 7.5B | ||
| +0.04% | -2.64% | +36.22% | -13.57% | 7.37B | ||
| -0.12% | -0.84% | +19.39% | +215.34% | 7.28B | ||
| -0.32% | -1.85% | -46.31% | +22.01% | 5.19B | ||
| Average | -0.16% | -2.35% | +13.38% | +75.55% | 16.57B | |
| Weighted average by Cap. | -0.22% | -1.85% | +21.08% | +82.39% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 16.7B 177M 152M 143M 130M 244M 245M 1.69B 655M 8.55B 663M 649M 27.25B | - |
| Net income | -1.14B -12.02M -10.34M -9.72M -8.88M -16.6M -16.65M -115M -44.56M -582M -45.14M -44.15M -1.85B | -2.93B -30.97M -26.63M -25.05M -22.87M -42.77M -42.91M -297M -115M -1.5B -116M -114M -4.78B |
| Net Debt | 5.62B 59.45M 51.13M 48.09M 43.9M 82.1M 82.37M 570M 220M 2.88B 223M 218M 9.17B | -1.25B -13.23M -11.38M -10.7M -9.77M -18.27M -18.33M -127M -49.04M -641M -49.68M -48.59M -2.04B |
Employees
111
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/09/26 | ₹12.40 | +1.97% | 5,073 |
| 07/09/26 | ₹12.16 | -0.49% | 19,641 |
| 04/09/26 | ₹12.22 | +0.58% | 15,096 |
| 03/09/26 | ₹12.15 | -0.98% | 9,226 |
| 02/09/26 | ₹12.27 | +1.40% | 25,472 |
- Stock Market
- Stocks
- NECLIFE Stock
- NECLIFE Stock
Select your edition
All financial news and data tailored to specific country editions

















